Close
Nordic 9Nordic 9

4BIO Capital (investor - Private Equity)

United Kingdom 4biocapital.com
See something wrong or missing? Let us know
Offices:London

4BIO CAPITAL is a trade name of 4BIO Ventures Management Ltd, a venture capital and public equities investors from the UK.

Average round investment:46.53M USD
Average number per year:2.0
Distribution: 2025 (2)2023 (3)2022 (1)2020 (2)
Portfolio companies: United Kingdom TrogenixNorway ActitheraUnited Kingdom ViaNautis See the entire list
Mostly invests in: United Kingdom United Kingdom (4) Biotech (8)
See the entire list

Showing 3 of 8 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to 4BIO Capital

Name Criteria
Belgium Belfius Bank
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Frog Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Hannover Digital Investments
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Elephant
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Palo Santo
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France eureKARE
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland Bombyx Capital Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Arab Emirates CE-Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Spain A&G Banca Privada
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Cyprus IREON Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top